Impact of troponin testing in noncardiac admissions
| Autor: | Jeffrey Murray, Andrew M. Keller, Joann R. Petrini, Bhooshan Perera, Rajesh Tota-Maharaj |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Coronary artery disease Patient Admission Risk Factors Diabetes mellitus Internal medicine Troponin I medicine Humans Aged biology Medical treatment business.industry Gastroenterology Angiotensin-converting enzyme Length of Stay Middle Aged musculoskeletal system medicine.disease Clopidogrel Troponin Cardiovascular Diseases Echocardiography cardiovascular system biology.protein Cardiology Female Cardiology and Cardiovascular Medicine business Biomarkers Kidney disease medicine.drug |
| Zdroj: | Critical pathways in cardiology. 13(4) |
| ISSN: | 1535-2811 |
| Popis: | BACKGROUND There is little data to support Troponin I (TNI) use in the management of noncardiac patients. We studied the use of TNI in patients on our gastroenterology service, to determine whether there was a change in management as a result of TNI testing. METHODOLOGY Patients admitted from September 2011 to June 2012 to our gastroenterology service who had TNI performed were included. Data collected included symptoms, cardiovascular risk factors, medical treatment, and testing. RESULTS Sixty-three of 295 patients had a positive TNI. The mean length of stay was significantly longer with a positive troponin (180 vs. 108 hours, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|